Special Issue "Marine Carotenoids"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 May 2014)

Special Issue Editors

Guest Editor
Prof. Dr. Kazuo Miyashita
Bio-functional Material Chemistry, Faculty of Fisheries Sciences, Hokkaido University, Hakodate 041-8611, Japan
E-Mail: kmiya@fish.hokudai.ac.jp
Phone: +81 138 408804
Fax: +81 138 408804

Guest Editor
Dr. Takashi Maoka
Research Institute for Production Development, 15 Shimogamo-morimoto-cho, Sakyo-ku, Kyoto 606-0805, Japan
E-Mail: maoka@mbox.kyoto-inet.or.jp
Phone: +81 757 811107
Fax: +81 757 917659

Special Issue Information

Dear Colleagues,

Carotenoids represent a large group of isoprenoid structures with many different structural characteristics and biological activities. They are the most important pigments among those occurring in the nature that are responsible for various colors of different fruits, vegetables and plant parts. Marine carotenoids are also responsible for the color of many fish and shellfish products. However, there has been a relatively little information on the impact of marine carotenoids on human health, while there have been so many papers and reviews on carotenoids from terrestrial origin.

The potential beneficial effects of marine carotenoids have been particularly focused on astaxanthin and fucoxanthin, as they are major marine carotenoids. Both carotenoids show strong antioxidant activity which is attributed to quenching singlet oxygen and scavenging free radicals. The potential role of the carotenoids as dietary antioxidants has been suggested as being one of the main mechanisms for their preventive effects against cancer and inflammatory et al. However, it will be difficult to explain their biological activities only by antioxidant activity. Other mechanisms of action that are independent of their antioxidant properties are also likely to be important. The mechanisms should be based on the regulatory effect of marine carotenoids on particular bio-molecules. This activity of carotenoids is responsible for the characteristic chemical structures which differ depending on the length of the polyene, nature of the end group and various substituent they contain.

This special issue of Marine Drugs is dedicated to marine carotenoids, and will be focused on the benefits of carotenoids to human being. For better understanding the physiological effects of marine carotenoids this issue should involve the most recent developments in presence, analysis, chemistry, and biochemistry of marine caroetnoids. We am very happy and honored to serve as a Guest Editor for this special issue, and would like to invite scientists to report their findings or review the recent literature on various aspects of marine carotenoids. I sincerely hope that this special issue will encourage other scientists to work on the exciting field of marine carotenoids.

Prof. Dr. Kazuo Miyashita
Dr. Takashi Maoka
Guest Editors

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • marine carotenoids
  • distribution
  • biosyntheis
  • absorption
  • metabolism
  • bioavailability
  • antioxidant activity
  • anti-cancer
  • prevention of cardiovascular disease
  • anti-atherosclerosis
  • anti-obesity
  • anti-diabetes
  • anti-inflammatory

Published Papers (18 papers)

by , , , ,  and
Mar. Drugs 2014, 12(7), 4214-4230; doi:10.3390/md12074214
Received: 4 June 2014; in revised form: 1 July 2014 / Accepted: 4 July 2014 / Published: 15 July 2014
Show/Hide Abstract | PDF Full-text (1463 KB) | HTML Full-text | XML Full-text

by , , ,  and
Mar. Drugs 2014, 12(6), 3660-3668; doi:10.3390/md12063660
Received: 10 March 2014; in revised form: 14 April 2014 / Accepted: 17 April 2014 / Published: 19 June 2014
Show/Hide Abstract | PDF Full-text (168 KB) | HTML Full-text | XML Full-text

by ,  and
Mar. Drugs 2014, 12(5), 2623-2632; doi:10.3390/md12052623
Received: 20 March 2014; in revised form: 15 April 2014 / Accepted: 15 April 2014 / Published: 8 May 2014
Show/Hide Abstract | PDF Full-text (716 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , ,  and
Mar. Drugs 2014, 12(4), 1773-1787; doi:10.3390/md12041773
Received: 10 December 2013; in revised form: 25 February 2014 / Accepted: 28 February 2014 / Published: 27 March 2014
Show/Hide Abstract | PDF Full-text (528 KB) | HTML Full-text | XML Full-text

by  and
Mar. Drugs 2014, 12(3), 1690-1698; doi:10.3390/md12031690
Received: 10 February 2014; in revised form: 3 March 2014 / Accepted: 4 March 2014 / Published: 24 March 2014
Show/Hide Abstract | PDF Full-text (508 KB) | HTML Full-text | XML Full-text

by ,  and
Mar. Drugs 2014, 12(3), 1460-1470; doi:10.3390/md12031460
Received: 16 January 2014; in revised form: 19 February 2014 / Accepted: 3 March 2014 / Published: 13 March 2014
Show/Hide Abstract | PDF Full-text (764 KB) | HTML Full-text | XML Full-text

by ,  and
Mar. Drugs 2014, 12(2), 964-982; doi:10.3390/md12020964
Received: 17 December 2013; in revised form: 22 January 2014 / Accepted: 23 January 2014 / Published: 14 February 2014
Show/Hide Abstract | PDF Full-text (1460 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , , , , , ,  and
Mar. Drugs 2011, 9(8), 1419-1427; doi:10.3390/md9081419
Received: 30 June 2011; in revised form: 31 July 2011 / Accepted: 8 August 2011 / Published: 22 August 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (232 KB) | HTML Full-text | XML Full-text

by , ,  and
Mar. Drugs 2011, 9(7), 1166-1175; doi:10.3390/md9071166
Received: 17 February 2011; in revised form: 26 May 2011 / Accepted: 15 June 2011 / Published: 27 June 2011
Show/Hide Abstract | Cited by 15 | PDF Full-text (158 KB) | HTML Full-text | XML Full-text

by
Mar. Drugs 2011, 9(6), 1101-1118; doi:10.3390/md9061101
Received: 2 May 2011; in revised form: 31 May 2011 / Accepted: 8 June 2011 / Published: 15 June 2011
Show/Hide Abstract | Cited by 43 | PDF Full-text (764 KB) | HTML Full-text | XML Full-text

by  and
Mar. Drugs 2011, 9(6), 1024-1037; doi:10.3390/md9061024
Received: 1 April 2011; in revised form: 3 June 2011 / Accepted: 7 June 2011 / Published: 10 June 2011
Show/Hide Abstract | Cited by 10 | PDF Full-text (386 KB) | HTML Full-text | XML Full-text

by
Mar. Drugs 2011, 9(5), 757-771; doi:10.3390/md9050757
Received: 21 March 2011; in revised form: 19 April 2011 / Accepted: 26 April 2011 / Published: 6 May 2011
Show/Hide Abstract | Cited by 4 | PDF Full-text (671 KB) | HTML Full-text | XML Full-text

by ,  and
Mar. Drugs 2011, 9(4), 625-644; doi:10.3390/md9040625
Received: 14 March 2011; Accepted: 14 April 2011 / Published: 20 April 2011
Show/Hide Abstract | Cited by 25 | PDF Full-text (299 KB) | HTML Full-text | XML Full-text

by  and
Mar. Drugs 2011, 9(3), 447-465; doi:10.3390/md9030447
Received: 7 February 2011; in revised form: 14 March 2011 / Accepted: 18 March 2011 / Published: 21 March 2011
Show/Hide Abstract | Cited by 22 | PDF Full-text (225 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , , ,  and
Mar. Drugs 2011, 9(3), 319-333; doi:10.3390/md9030319
Received: 31 January 2011; in revised form: 15 February 2011 / Accepted: 17 February 2011 / Published: 3 March 2011
Show/Hide Abstract | Cited by 28 | PDF Full-text (241 KB) | HTML Full-text | XML Full-text

by
Mar. Drugs 2011, 9(2), 278-293; doi:10.3390/md9020278
Received: 14 January 2011; in revised form: 16 February 2011 / Accepted: 21 February 2011 / Published: 22 February 2011
Show/Hide Abstract | Cited by 24 | PDF Full-text (271 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2011, 9(2), 242-255; doi:10.3390/md9020242
Received: 22 December 2010; in revised form: 25 January 2011 / Accepted: 4 February 2011 / Published: 10 February 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (493 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

by , ,  and
Mar. Drugs 2011, 9(1), 29-42; doi:10.3390/md9010029
Received: 2 November 2010; in revised form: 18 December 2010 / Accepted: 23 December 2010 / Published: 24 December 2010
Show/Hide Abstract | Cited by 7 | PDF Full-text (579 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 30 October 2013

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert